| Product Code: ETC9950406 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Oncology Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Oncology Market - Industry Life Cycle |
3.4 United Kingdom (UK) Oncology Market - Porter's Five Forces |
3.5 United Kingdom (UK) Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 United Kingdom (UK) Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United Kingdom (UK) Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in the UK population |
4.2.2 Advances in oncology treatments leading to improved survival rates |
4.2.3 Growing adoption of precision medicine in oncology |
4.3 Market Restraints |
4.3.1 High cost of oncology treatments and therapies |
4.3.2 Stringent regulatory requirements for drug approvals |
4.3.3 Limited access to innovative oncology treatments in certain regions of the UK |
5 United Kingdom (UK) Oncology Market Trends |
6 United Kingdom (UK) Oncology Market, By Types |
6.1 United Kingdom (UK) Oncology Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Oncology Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Oncology Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.4 United Kingdom (UK) Oncology Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.1.5 United Kingdom (UK) Oncology Market Revenues & Volume, By Colon & rectal cancer, 2021- 2031F |
6.1.6 United Kingdom (UK) Oncology Market Revenues & Volume, By Gastric cancer, 2021- 2031F |
6.1.7 United Kingdom (UK) Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Oncology Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 United Kingdom (UK) Oncology Market Revenues & Volume, By Diagnostic laboratories, 2021- 2031F |
6.2.4 United Kingdom (UK) Oncology Market Revenues & Volume, By Diagnostic imaging centers, 2021- 2031F |
6.2.5 United Kingdom (UK) Oncology Market Revenues & Volume, By Academia, 2021- 2031F |
6.2.6 United Kingdom (UK) Oncology Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.2.7 United Kingdom (UK) Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Oncology Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Oncology Market Export to Major Countries |
7.2 United Kingdom (UK) Oncology Market Imports from Major Countries |
8 United Kingdom (UK) Oncology Market Key Performance Indicators |
8.1 Patient survival rates for different types of cancer |
8.2 Adoption rate of precision medicine in oncology practices |
8.3 Number of clinical trials for new oncology treatments in the UK |
9 United Kingdom (UK) Oncology Market - Opportunity Assessment |
9.1 United Kingdom (UK) Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 United Kingdom (UK) Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United Kingdom (UK) Oncology Market - Competitive Landscape |
10.1 United Kingdom (UK) Oncology Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here